Stent Thrombosis In Acute Coronary Syndromes
Contemporary Treatment Of Stent Thrombosis In Acute Coronary Syndromes
2 other identifiers
observational
800
1 country
1
Brief Summary
The purpose of this study is to better understand what treatment methods result in the best outcomes for patients who have heart attacks due to blood clots forming within stents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 29, 2009
CompletedFirst Posted
Study publicly available on registry
July 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedMarch 2, 2018
March 1, 2018
8.8 years
June 29, 2009
March 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To describe current real world practice in the treatment of ACS due to stent thrombosis.
3 years
Secondary Outcomes (1)
To describe early and long term follow up of patients who are treated for ACS due to stent thrombosis.
3 years
Eligibility Criteria
Patients who have had a heart attack or almost have had a heart attack due to blood clots forming within previously placed stents.
You may qualify if:
- Subject's age range will be ≥ 18 years old.
- Subjects will have an existing drug-eluting or bare metal stent.
- Subjects will have presented to the Medical Center with Acute Coronary Syndrome due to stent thrombosis as identified via cardiac catheterization.
You may not qualify if:
- Inability to consent/declined to participate in the prospective arm of the clinical registry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC Davis Medical Center
Sacramento, California, 95817, United States
Related Publications (3)
Reeves RR, Patel M, Armstrong EJ, Sab S, Waldo SW, Yeo KK, Shunk KA, Low RI, Rogers JH, Mahmud E. Angiographic characteristics of definite stent thrombosis: role of thrombus grade, collaterals, epicardial coronary flow, and myocardial perfusion. Catheter Cardiovasc Interv. 2015 Jan 1;85(1):13-22. doi: 10.1002/ccd.25519. Epub 2014 May 7.
PMID: 24753053DERIVEDWaldo SW, Armstrong EJ, Yeo KK, Patel M, Reeves R, Macgregor JS, Low RI, Mahmud E, Rogers JH, Shunk K. Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis. Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1048-53. doi: 10.1002/ccd.25007. Epub 2013 Jul 2.
PMID: 23703925DERIVEDArmstrong EJ, Yeo KK, Javed U, Mahmud E, Patel M, Shunk KA, MacGregor JS, Low RI, Rogers JH. Angiographic stent thrombosis at coronary bifurcations: short- and long-term prognosis. JACC Cardiovasc Interv. 2012 Jan;5(1):57-63. doi: 10.1016/j.jcin.2011.09.015.
PMID: 22230151DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Rogers, MD
University of California, Davis
- PRINCIPAL INVESTIGATOR
Khung Keong Yeo, MD
University of California, Davis
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2009
First Posted
July 2, 2009
Study Start
April 1, 2008
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
March 2, 2018
Record last verified: 2018-03